The compliance clock is ticking loudly in health insurance these days. And one New York startup is betting it can turn that urgency into lasting market position.
Anterior, an AI platform targeting one of healthcare's most reviled administrative bottlenecks—prior authorization—pulled in $40 million in fresh funding on February 12, oversubscribing the round despite what many investors would call a challenging environment for health tech deals. The raise brings the company's total haul to $64 million since its 2022 founding, with backing from heavyweights NEA and Sequoia, along with newcomers FPV Ventures and Kinnevik.
The timing tells you almost everything. January 1, 2026 marked the first hard deadline under CMS's Interoperability & Prior Authorization Final Rule—the one that forces Medicare Advantage, Medicaid, and CHIP plans to make prior auth decisions within 72 hours for urgent cases and seven days for standard reviews. More requirements arrive in 2027, when API mandates take effect. Health plans that spent years complaining about the rules are now scrambling to comply, and that scramble has opened a window for companies like Anterior.
Whether that window stays open long enough to build defensible market share? That's the gamble.
Money Following Deployment Numbers
Anterior—which operated under the more obscure name Co:Helm until recently—raised $20 million in Series A funding back in June 2024 at a $95 million post-money valuation, with NEA leading. Before that came a $3.2 million seed round in September 2023, led by Sequoia Arc. The escalation suggests investor confidence, or at least comfort with the regulatory pressure building behind the company's sales pitch.
The new capital will fund what Anterior calls production deployments, not just pilot programs. The company is also developing use cases beyond prior authorization, venturing into payment integrity, risk adjustment, care management, and appeals—adjacent workflows where similar automation logic might apply. Anterior highlighted plans to accelerate its "five-day average deployment" model, a curious metric for software but one that matters when clients face imminent deadlines.
Integrations are expanding too. The company name-checked HealthEdge's GuidingCare platform as one ecosystem partner, signaling the kind of payer infrastructure tie-ins required to actually move utilization management decisions at scale.
"We're supporting organizations covering 50 million lives," the company announced, noting deployments that process more than 8 million prior authorizations annually. That's real volume, though context matters—roughly 45 million prior authorization requests flow through the U.S. healthcare system every week, according to AMA estimates, so Anterior is capturing a slice, not the whole pie.
Clinical Staff Embedded in Software
CEO Abdel Mahmoud, a former physician who logged time in product roles at Facebook and Google, co-founded Anterior in 2022 alongside CTO Zahid Mahmood. Their pitch centers on "Florence," an end-to-end platform that automates prior authorization workflows while claiming 99.24% clinical accuracy, validated by KLAS Research. The company also touts an 85% reduction in baseline administrative costs and 56% cut in staff burden time.
Those are aggressive claims in a sector littered with overpromised automation. What makes Anterior's model distinct, maybe, is what it calls "Forward Deployed Clinicians"—embedding actual clinical staff alongside health plan teams to tune AI performance and smooth adoption. It's an unusual approach for a software startup, one that resembles consulting as much as SaaS. But perhaps that's intentional. Trust gaps between algorithms and the nurses who review auth requests don't close by themselves, and Anterior seems to be betting that human-in-the-loop design will accelerate uptake.
KLAS named Anterior a 2025 "Points of Light" case study, based on work with delegated utilization management partner WNS-HealthHelp. The company claims 76% increases in auto-approvals, 155-second average auto-approval processing times, and 38 nurse-days saved per 1,000 reviews. Named customers now include Geisinger Health Plan, MedWatch, and WNS-HealthHelp, though the client roster remains modest for a company processing millions of decisions annually—suggesting some large, unnamed payer relationships.
Regulatory Pressure as Market Catalyst
The CMS rule finalized in January 2024 isn't subtle. Beyond decision timeframe mandates already in force, payers must implement Patient Access APIs, Provider Access APIs, and Prior Authorization APIs by January 2027. Non-compliance carries financial and operational consequences, the kind that make C-suites authorize software budgets they might otherwise defer.
Anterior shored up its advisory bench with the funding, adding David Shulkin (former VA Secretary), Peter Long (ex-Blue Shield of California EVP, now on the BCBS Massachusetts board), and William Golden (former CEO of UnitedHealthcare Employer & Individual). That's serious pedigree—the type of advisors who can open doors at health plans and speak credibly about utilization management pain points.
The investor mix also signals something. NEA and Sequoia don't typically back pure-play model companies; they want deployment traction and enterprise motion. Digital health funding hit $14.2 billion across 482 deals in 2025, per Rock Health, with AI-enabled startups capturing 62% of first-half funding and commanding larger round sizes than their non-AI peers. Megadeals over $100 million accounted for 42% of all capital, meaning mid-sized raises like Anterior's sit in a competitive middle tier.
Crowded Field, Narrow Window
Anterior isn't alone in this market. Cohere Health raised a $90 million Series C in May 2025, dwarfing Anterior's Series A. Network-scale platforms like Availity's Intelligent UM already have established distribution. And legacy players—Change Healthcare (pre and post-breach), Zelis, MultiPlan—aren't sitting idle as startups encroach on utilization management workflows.
Anterior's 51–200 employee headcount and offices in New York, London, and Colorado suggest the kind of payer-embedded work its Forward Deployed model demands. But it also means higher operating costs than pure software plays. Scaling that model without diluting margins will test management execution.
The company's expansion into adjacent workflows—payment integrity, risk adjustment, appeals—makes strategic sense. Prior authorization alone may not sustain venture-scale returns, and broadening the platform could increase stickiness with payer clients already integrated. Whether Anterior can move fast enough to capitalize on the compliance window before larger incumbents close the gap is the real question.
For now, the company has capital, customer traction, and federal deadlines working in its favor. The operational teeth behind those CMS mandates are real, and health plans will spend to avoid penalties. What happens after compliance stabilizes—when the urgency fades and payers start evaluating platforms on ROI rather than deadline pressure—will determine whether Anterior's bet pays off or becomes another cautionary tale in health tech's long history of regulatory-driven hype cycles.
